Last Updated: May 3, 2026

VITAMIN D Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Vitamin D

A generic version of VITAMIN D was approved as ergocalciferol by CHARTWELL RX on May 20th, 2009.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for VITAMIN D?
  • What are the global sales for VITAMIN D?
  • What is Average Wholesale Price for VITAMIN D?
Pharmacology for VITAMIN D

US Patents and Regulatory Information for VITAMIN D

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma VITAMIN D ergocalciferol CAPSULE;ORAL 080704-001 Approved Prior to Jan 1, 1982 AA RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
West Ward VITAMIN D ergocalciferol CAPSULE;ORAL 083102-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Everylife VITAMIN D ergocalciferol CAPSULE;ORAL 080956-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Molecular VITAMIN D ergocalciferol CAPSULE;ORAL 080825-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chase Chem VITAMIN D ergocalciferol CAPSULE;ORAL 080747-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Vitamin D

Last updated: February 17, 2026

What are the key drivers shaping the vitamin D market?

The global vitamin D market has experienced steady growth driven by increased awareness of deficiency-related health issues, expanding applications in pharmaceutical, nutraceutical, and functional food sectors, and rising consumer health consciousness. The demand signals are amplified by an aging population, with older adults at higher risk for osteoporosis and autoimmune diseases, and the surge in preventive healthcare practices.

Major factors include:

  • Health awareness campaigns emphasizing vitamin D's role in bone health and immune function.
  • Fortification of foods and beverages, boosting demand for vitamin D ingredients.
  • Development of novel formulations—emulsions, sprays, and gummies—that improve bioavailability and consumer appeal.
  • Regulatory environment, with some nations recommending daily intake guidelines that influence supplement sales.

How has the COVID-19 pandemic affected market growth?

The pandemic influenced the market in multiple ways:

  • Elevated interest in vitamin D supplements as a preventive measure against respiratory infections.
  • Disruption in supply chains initially caused shortages but stabilized subsequently.
  • Increased consumer spending on immunity-boosting products, accelerating market growth rates.

What are the primary applications and market segments?

The market segmentation includes:

Segment Description Estimated Market Share (2022) Key Trends
Dietary Supplements Capsules, tablets, gummies; most popular segment 65% Rise in online sales, direct-to-consumer
Food Fortification Dairy, cereals, beverages; mandated in select regions 20% Growth driven by regulatory policies
Pharmaceuticals Prescribed high-dose formulations for deficiency treatment 10% Focus on clinical applications
Others Animal nutrition, cosmetics 5% Emerging applications

What are the major market players and patent landscape?

Leading companies include:

  • DSM: Innovates with bioavailable forms and controlled-release formulations.
  • Alfacell: Focuses on high-dose prescription versions.
  • Matsutani: Supplies natural vitamin D3 derived from lanolin or lichen.
  • BASF and Nichiiko: Large-scale producers supplying bulk vitamin D3.

Patent activity is concentrated around novel delivery systems and stabilization technologies. Key patents will expire between 2025 and 2030, opening opportunities for generic formulations and biosimilars.

What is the financial outlook and projected growth trajectory?

The global vitamin D market size was valued at approximately USD 1.2 billion in 2022. Compound annual growth rate (CAGR) projections range from 7% to 9% through 2030.

Year Market Size (USD billion) CAGR (2022–2030)
2022 1.2 --
2025 1.8 – 2.0 7% – 8%
2030 2.4 – 2.6 8% – 9%

Segments like functional foods and pharmaceuticals are expected to lead growth due to innovation and expanded applications.

How do regulatory policies influence market growth?

Safety and efficacy standards vary:

  • The U.S. FDA classifies vitamin D as a dietary supplement with established daily intake levels (~15 μg for adults).
  • The European Food Safety Authority (EFSA) permits up to 100 μg/day, considering it safe.
  • Countries with fortification mandates, like Canada, impact domestic market expansion.

Stringent regulations can both restrict and catalyze innovation, as companies develop formulations that meet diverse compliance standards.

What are the potential risks and barriers?

Risks include:

  • Market oversaturation due to low entry barriers in supplement segments.
  • Regulatory changes that limit high-dose formulations.
  • Consumer skepticism about supplement efficacy and safety.
  • Price competition from emerging manufacturers.

Barriers involve supply chain disruptions, particularly for natural sourcing of vitamin D3, and batch-to-batch consistency challenges.

What are the key opportunities for investment and R&D?

Opportunities include:

  • Developing plant-based or sustainable vitamin D sources (e.g., lichen-derived D3).
  • Innovating delivery formats to improve bioavailability and consumer adherence.
  • Pursuing personalized vitamin D supplementation based on genetic or serum level testing.
  • Exploring synergistic formulations with calcium, magnesium, or other nutrients.

Key Takeaways

  • The vitamin D market grew from USD 1.2 billion in 2022, with a CAGR of 7–9% projected until 2030.
  • Growth is driven by health awareness, food fortification, and immunity-related applications.
  • Major players are focusing on formulation innovation, with patent expiries opening opportunities.
  • Regulatory frameworks strongly influence product development and market entry.
  • Emerging sources, personalized products, and delivery innovations constitute strategic opportunities.

Frequently Asked Questions

Q1: Which segments will see the fastest growth?
Functional foods and pharmaceutical applications, due to consumer demand for health-centric products and medical treatments.

Q2: What regions are leading the market?
North America leads, followed by Europe, with Asia-Pacific expected to witness the highest growth rates driven by population size and rising health consciousness.

Q3: How will patent expirations impact the market?
Patent expirations between 2025 and 2030 will facilitate generic entry, increasing competition and reducing prices.

Q4: What are the main challenges for new entrants?
Regulatory compliance, sourcing sustainable ingredients, and establishing distribution channels.

Q5: Will natural or synthetic vitamin D dominate?
Natural sources, like lanolin and lichen, are gaining favor due to consumer preference and sustainability trends, but synthetic D3 remains prevalent for cost efficiency.

References

[1] Allied Market Research. (2022). Vitamin D Market by Source and Application: Global Opportunity Analysis.
[2] European Food Safety Authority. (2022). Scientific opinion on the safety of vitamin D in food supplements.
[3] U.S. Food and Drug Administration. (2023). Dietary Supplements: Safety and Efficacy Guidelines.
[4] MarketsandMarkets. (2023). Vitamin D Market by Source (Natural, Synthetic), Application, and Region: Global Forecast to 2030.
[5] Grand View Research. (2022). Nutraceutical Ingredients Market Size and Trend Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.